Danforth Advisors completed the acquisition of Advyzom.

Danforth Advisors, a provider of outsourced corporate and clinical business functions for the life science industry, completed the acquisition of Advyzom, a boutique consulting company specializing in highly strategic regulatory and development advice and services. Financial terms were not disclosed. “Advyzom brings top talent and an exceptional track record in regulatory strategy, timely execution, and positive working relationships with health authorities – all critical to achieving clients’ drug development and commercialization objectives. We now have a fully integrated suite of clinical and regulatory services that can adapt to every stage of development," Chris Connors, Danforth Advisors CEO.